LENSAR, Inc. (LNSR) vs Zomedica Corp. (ZOMDF)
LENSAR, Inc. and Zomedica Corp. are both Medical Devices companies. LENSAR, Inc. and Zomedica Corp. are of similar size ($95.4M and $86.9M). Zomedica Corp. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.4×. Zomedica Corp. grew revenue faster over the last twelve months: 30.1% against 3.26%. LENSAR, Inc. has the higher net margin (57.6% vs −51.4%) and the lower return on invested capital (−379.0% vs −20.5%). Across the 16 metrics below, LENSAR, Inc. leads on 8 and Zomedica Corp. on 8.
Valuation
Profitability
| Metric | LNSR | ZOMDF | Medical Devices median |
|---|---|---|---|
| Gross margin | 48.34% | 65.44% | 56.01% |
| Operating margin | (13.48%) | (56.28%) | (15.03%) |
| Net margin | 57.57% | (51.39%) | (20.40%) |
| Free cash flow margin | (12.29%) | (40.75%) | (7.24%) |
| Return on equity | (851.75%) | (16.29%) | (15.32%) |
| Return on assets | 49.58% | (14.88%) | (19.72%) |
| Return on invested capital | (379.01%) | (20.54%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack